Blog
Finasteride by Injection
Daewoong Pharmaceutical, a bioengineering company in South Korea, has been cleared to begin a first-stage clinical trial of a long-acting male baldness medication called “IVL3001” in Australia.
IVL3001 is injected once a month or once every three months and has been shown to deliver better effects than oral drugs, even at a lower dose. IVL3001contains finasteride-loaded polymer microspheres that deliver Finasteride, one of only two drugs approved by the FDA for hair growth. Daewoong anticipates that IVL3001 will reduce the inconvenience taking an oral drug every day at the same time as improving hair growth. Daewoong plans to establish a corporation in Maryland to expand its presence in North America.
Post Views: 479
Related Posts
The Topical Finasteride Reality Check
Topical finasteride may reduce scalp DHT and improve hair counts, but “topical” is not the same as “local only.”
Autumn Shedding
More hair in the brush can be alarming. When it happens as summer ends, you can be reassured that it is probably “the fall shed”— a seasonal event that requires patience more than anxiety.
The Thinning Hair Attachment Safety Guide
Added hair can provide immediate volume, but fine or actively thinning hair may have little capacity to carry additional weight. Safe practice begins with assessment—not attachment.
Whatever Happened to Hair Cloning?
About Retirement
For decades, hair cloning has been described as the ultimate answer to baldness: take a few healthy follicles, multiply...
When Hair Is Not Enough
For decades, hair restoration has occupied a central place in the conversation about male appearance and confidence.
New Hope for Teens Facing Sudden Hair Loss
New clinical results suggest that treatments already helping adults with severe alopecia
Is Finasteride Finally Losing Its Grip?
Cosmo Pharmaceuticals has reported positive Phase 3 results for topical clascoterone 5%,
Inside the New Drug Pipeline
Investors are pouring capital into hair-loss research, demonstrating confidence that science may
What If You Could See the Future You?
Discover how new technology reveals the emotional impact of hair restoration ;boosting self-esteem through innovative solutions.
Independent Hair News Source Joins Telehealth Brand
In a notable development in the hair restoration industry, Follicle Thought has announced a formal partnership with Ulo, a new U.S.-based telehealth brand focused on personalized hair care.
Cambridge Researchers Harnessing Cellular Energy
Cambridge Researchers announce mitochondrial breakthrough with hair growth potential using cellular energy.
Hair, Health, and Hope
A new wave of business innovation is underway—one that prioritizes not only how long we live, but how well we live.